Comparison of two chromogenic FVIII activity assays to a standard clot-based FVIII activity assay

被引：0
|
作者：
McGlasson, D. L. [1 ]
Fritsma, G. A. [2 ]
机构：
[1] 59th Clin Res Div, Lab Serv, Lackland AFB, TX USA
[2] Fritsma Factor, Hemostasis Connect, Birmingham, AL USA
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2009年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PP-WE-235
引用
收藏
页码：706 / 706
页数：1
相关论文
共 50 条
  • [1] Comparison of clot-based and chromogenic assay for the determination of protein c activity
    Roshan, Tariq M.
    Stein, Nancy
    Jiang, Xiu Y.
    BLOOD COAGULATION & FIBRINOLYSIS, 2019, 30 (04) : 156 - 160
  • [2] Comparison of Clot-Based vs Chromogenic Factor Xa Procoagulant Phospholipid Activity Assays
    Bohling, Sandra D.
    Pagano, Monica B.
    Stitzel, Maria R.
    Ferrell, Chris
    Yeung, Wandy
    Chandler, Wayne L.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 137 (02) : 185 - 192
  • [3] ONE STAGE CHRONOMETRIC FVIII ASSAY OR TWO STAGE CHROMOGENIC FVIII ASSAY TO DIAGNOSE HAEMOPHILIA A?
    Marchand, K.
    Benoit, R.
    Martin, M.
    Fretigny, M.
    Toussaint-Hacquard, M.
    Frotscher, B.
    HAEMOPHILIA, 2022, 28 : 30 - 30
  • [4] Influence of FIX and FVIII PEGYLATION on FIX and FVIII activity based on APTT assays
    Lochu, A.
    Romari, N.
    Beltran, J.
    Magdelaine, A.
    Ezban, M.
    Hermit, M. B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 970 - 970
  • [5] Chromogenic and Clot-Based Bivalirudin Assays for Monitoring Anticoagulation
    Raghavendran, Prashant
    Tillman, Benjamin F.
    Wheeler, Allison P.
    Gailani, David
    JOURNAL OF APPLIED LABORATORY MEDICINE, 2023, 8 (06): : 1074 - 1083
  • [6] Assay Interference By Emicizumab in Aptt and Chromogenic Based FVIII:C and Inhibitor Assays
    Poirier, Brian F.
    Robinson, Mary
    Tiefenbacher, Stefan
    McEwan, Erin
    Cogswell, Caroline
    Gode, Roxy
    Burger, Emily
    Allison, Tyler
    Littlefield, Jennifer
    Pikas, Amanda
    Schmoker, Andrea
    BLOOD, 2020, 136
  • [7] DIFFERENTIAL DETERMINATION OF INNATE VS RECOMBINANT COAGULATION FACTOR 8 ACTIVITY MEASUREMENT USING CLOT-BASED ASSAY AND CHROMOGENIC ASSAYS
    Bynagari, Yamini S.
    Newton, Hannah
    Cota, Jacob
    Chang, Sunghee
    Azzolino, Joey
    Ero, Mike
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (09) : E9 - E9
  • [8] Usefulness of Chromogenic Assay in Measuring FVIII Activity of Hemophiliac Patients Receiving Emicizumab
    Yamaguchi, Tomoko
    Inaba, Hiroshi
    Miyashita, Ryui
    Kamikubo, Yoshiko
    Chikasawa, Yushi
    Yotsumoto, Mihoko
    Shinozawa, Keiko
    Hagiwara, Takeshi
    Amano, Kagehiro
    Kinai, Ei
    PEDIATRIC BLOOD & CANCER, 2020, 67
  • [9] Comparison of clot-based and chromogenic assays for measurement of factor VIII inhibitors in haemophilia A patients
    Jabri, A.
    Said, M.
    Ghali, O.
    Ben Lakhal, F.
    Salem, S. Fekih
    Riahi, M.
    Nakhla, Y.
    Gouider, E.
    El Borgi, W.
    HAEMOPHILIA, 2024, 30 : 40 - 41
  • [10] FVIII activity of OBIZUR can be measured in hemophilic plasma with standard FVIII one-stage clotting assays
    Turecek, Peter L.
    Novack, Aaron R.
    Apostol, Claudia
    Romeder-Finger, Stefan
    Bauer, Alexander
    Burger, Divan
    Gritsch, Herbert
    HAEMOPHILIA, 2016, 22 : 4 - 4
12345